Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | AGK-2 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.022 | 0.7 |
mRNA | CCT018159 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | -0.03 | 0.7 |
mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | GSK525762A | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | BRD-A86708339 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |